The Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA; Allergan) for the treatment of upper limb spasticity in pediatric patients 2-17 years of age. The approval was based on ...
The US Food and Drug Administration (FDA) has approved onabotulinumtoxinA (Botox, Allergan) to ease upper limb spasticity in children and adolescents aged 2 to 17 years, the company announced. Common ...
Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...
Allergan plc AGN announced that the FDA has approved its supplemental biologics license application (sBLA) to expand the label of its blockbuster product Botox for pediatric patients with upper limb ...
DUBLIN, March 7, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental biologics license applications ...
- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...
Please provide your email address to receive an email when new articles are posted on . Allergan announced that the FDA has approved its supplemental biologics application for Botox, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback